SoftBank Vision Fund 2 led a $219m funding round in Elemy, a autism-care provider. Additional investors include Goodwater Capital, Premji Invest, Metrodora Ventures, Amity Ventures, Avidity Partners, Whale Rock Capital, Sound Ventures, Bling Capital, Felicis Ventures, Founders Fund, General Catalyst, Headline, SignalFire, and 8VC. "The company “has the potential to improve the current standard of treatment for pediatric autism and deliver measurable outcomes," Andrew Zloto, a SoftBank Investment Advisers Director.